Patents Assigned to IMMUNOLOGIK GMBH
  • Agents for the treatment of retroviral infectious diseases
    Patent number: 10588896
    Abstract: The invention relates to pyridine-3,5-bis-thiocyanates which are new active substances for the treatment and prevention of retroviral infections and secondary diseases thereof, in particular HIV infections and AIDS, from the group of deubiquitinase inhibitors. Administration of the compounds of the invention increases the immunogenicity of viral proteins and thus the antiviral response.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: March 17, 2020
    Assignee: IMMUNOLOGIK GMBH
    Inventors: Ulrich Schubert, Christian Setz, Wolfgang Brysch, Jörg Von Wegerer
  • AGENTS FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES
    Publication number: 20170202814
    Abstract: The invention relates to pyridine-3,5-bis-thiocyanates which are new active substances for the treatment and prevention of retroviral infections and secondary diseases thereof, in particular HIV infections and AIDS, from the group of deubiquitinase inhibitors. Administration of the compounds of the invention increases the immunogenicity of viral proteins and thus the antiviral response.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 20, 2017
    Applicant: IMMUNOLOGIK GMBH
    Inventors: Ulrich Schubert, Christian Setz, Wolfgang Brysch, Jörg Von Wegerer